Scrip RSS Feedhttps://insights.citeline.comThe Latest News & Analysis from ScripThu, 22 Oct 2026 01:23:53 +0000en1hourly1 https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-astrazenecas-breztri-aerosphere-wins-us-approval-in-copd-and-asthma-QXW5DXV6CBBQZODVDYP4L3P74I/<![CDATA[Pipeline Watch: AstraZeneca’s Breztri Aerosphere Wins US Approval in COPD and Asthma]]>premium

      
]]> https://feeds.feedblitz.com/~/971848499/0/scrip~Pipeline-Watch-AstraZeneca%e2%80%99s-Breztri-Aerosphere-Wins-US-Approval-in-COPD-and-Asthma/https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-astrazenecas-breztri-aerosphere-wins-us-approval-in-copd-and-asthma-QXW5DXV6CBBQZODVDYP4L3P74I/
      
]]> Wed, 21 Oct 2026 14:00:49 +0000 https://insights.citeline.com/scrip/new-products/gsks-hibsago-will-transform-hep-b-treatment-but-leaves-room-for-improvement-ZG72MWH2KVHBTI6HZ77XB375SQ/<![CDATA[GSK’s Hibsago Will Transform Hep B Treatment But Leaves Room For Improvement]]>premium

      
]]> https://feeds.feedblitz.com/~/971848496/0/scrip~GSK%e2%80%99s-Hibsago-Will-Transform-Hep-B-Treatment-But-Leaves-Room-For-Improvement/https://insights.citeline.com/scrip/new-products/gsks-hibsago-will-transform-hep-b-treatment-but-leaves-room-for-improvement-ZG72MWH2KVHBTI6HZ77XB375SQ/
      
]]> Wed, 21 Oct 2026 14:12:24 +0000 https://insights.citeline.com/scrip/leadership/interviews/can-adcs-plus-pd-l1xvegf-bispecifics-be-a-new-backbone-in-cancer-AF4Q5UUWKFCIPI4OB3DZ5YTCGU/<![CDATA[Can ADCs Plus PD-(L)1xVEGF Bispecifics Be A New Backbone In Cancer?]]>premium

      
]]> https://feeds.feedblitz.com/~/971857319/0/scrip~Can-ADCs-Plus-PDLxVEGF-Bispecifics-Be-A-New-Backbone-In-Cancer/https://insights.citeline.com/scrip/leadership/interviews/can-adcs-plus-pd-l1xvegf-bispecifics-be-a-new-backbone-in-cancer-AF4Q5UUWKFCIPI4OB3DZ5YTCGU/
      
]]> Wed, 21 Oct 2026 18:28:28 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/roivant-plots-commercial-strategy-as-lisraya-scores-big-in-niu-72FFRRC42JEVTARAHP4HGM4Z6Q/<![CDATA[Roivant Plots Commercial Strategy As Lisraya Scores Big In NIU ]]>premium

      
]]> https://feeds.feedblitz.com/~/971860271/0/scrip~Roivant-Plots-Commercial-Strategy-As-Lisraya-Scores-Big-In-NIU/https://insights.citeline.com/scrip/r-and-d/clinical-trials/roivant-plots-commercial-strategy-as-lisraya-scores-big-in-niu-72FFRRC42JEVTARAHP4HGM4Z6Q/
      
]]> Wed, 21 Oct 2026 20:52:59 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/lumen-seeks-partner-take-its-c-diff-cocktail-into-phase-iii-5UUGDGXRR5HIJATJK7UPHXOQ6Q/<![CDATA[Lumen Seeks Partner Take Its C. Diff Cocktail Into Phase III]]>premium

      
]]> https://feeds.feedblitz.com/~/971860886/0/scrip~Lumen-Seeks-Partner-Take-Its-C-Diff-Cocktail-Into-Phase-III/https://insights.citeline.com/scrip/r-and-d/clinical-trials/lumen-seeks-partner-take-its-c-diff-cocktail-into-phase-iii-5UUGDGXRR5HIJATJK7UPHXOQ6Q/
      
]]> Wed, 21 Oct 2026 21:20:37 +0000 https://insights.citeline.com/scrip/all-in-on-adcs-drug-developers-shift-attention-to-the-next-generation-JDLAGDYD2JAPNBGMUB7HQTFB5I/<![CDATA[All In On ADCs: Drug Developers Shift Attention To The Next Generation ]]>premium

      
]]> https://feeds.feedblitz.com/~/971828561/0/scrip~All-In-On-ADCs-Drug-Developers-Shift-Attention-To-The-Next-Generation/https://insights.citeline.com/scrip/all-in-on-adcs-drug-developers-shift-attention-to-the-next-generation-JDLAGDYD2JAPNBGMUB7HQTFB5I/
      
]]> Tue, 20 Oct 2026 21:04:54 +0000Love Employee https://insights.citeline.com/scrip/r-and-d/clinical-trials/amgen-astrazeneca-detail-phase-iii-data-for-tezspires-likely-third-indication-IR6YOUMFDJDK5KCMEA2YN72C5M/<![CDATA[Amgen, AstraZeneca Detail Phase III Data For Tezspire’s Likely Third Indication]]>premium

      
]]> https://feeds.feedblitz.com/~/971829491/0/scrip~Amgen-AstraZeneca-Detail-Phase-III-Data-For-Tezspire%e2%80%99s-Likely-Third-Indication/https://insights.citeline.com/scrip/r-and-d/clinical-trials/amgen-astrazeneca-detail-phase-iii-data-for-tezspires-likely-third-indication-IR6YOUMFDJDK5KCMEA2YN72C5M/
      
]]> Tue, 20 Oct 2026 22:06:49 +0000 https://insights.citeline.com/scrip/business/stock-watch/stock-watch-jjs-pharma-strength-has-its-limits-TOCDHLSUANCE5NPVZRCKUF34II/<![CDATA[Stock Watch: J&J’s Pharma Strength Has Its Limits]]>premium

      
]]> https://feeds.feedblitz.com/~/971809976/0/scrip~Stock-Watch-JJ%e2%80%99s-Pharma-Strength-Has-Its-Limits/https://insights.citeline.com/scrip/business/stock-watch/stock-watch-jjs-pharma-strength-has-its-limits-TOCDHLSUANCE5NPVZRCKUF34II/
      
]]> Tue, 20 Oct 2026 11:32:43 +0000 https://insights.citeline.com/scrip/business/deals/ambrose-adopts-results-driven-model-to-acquire-am-pharma-CVPS3M4C7FG37JWRU7YNOW5FZI/<![CDATA[Ambrose Adopts Results-Driven Model To Acquire AM-Pharma ]]>premium

      
]]> https://feeds.feedblitz.com/~/971815733/0/scrip~Ambrose-Adopts-ResultsDriven-Model-To-Acquire-AMPharma/https://insights.citeline.com/scrip/business/deals/ambrose-adopts-results-driven-model-to-acquire-am-pharma-CVPS3M4C7FG37JWRU7YNOW5FZI/
      
]]> Tue, 20 Oct 2026 14:30:20 +0000 https://insights.citeline.com/scrip/conferences/esmo/esmo-2026-what-moderna-merck-roche-astrazeneca-and-others-need-from-phase-iii-data-6LMQRS27LZGYNBBYOW7Z5BQONA/<![CDATA[ESMO 2026: What Moderna, Merck, Roche, AstraZeneca And Others Need From Phase III Data]]>premium

      
]]> https://feeds.feedblitz.com/~/971786807/0/scrip~ESMO-What-Moderna-Merck-Roche-AstraZeneca-And-Others-Need-From-Phase-III-Data/https://insights.citeline.com/scrip/conferences/esmo/esmo-2026-what-moderna-merck-roche-astrazeneca-and-others-need-from-phase-iii-data-6LMQRS27LZGYNBBYOW7Z5BQONA/
      
]]> Mon, 19 Oct 2026 16:28:53 +0000 https://insights.citeline.com/scrip/digital-technologies/ai/astrazeneca-extends-ai-pacts-to-clinical-trials-with-oracle-tie-up-DO64GUILINAPPFWD7WC7Y6SBGU/<![CDATA[AstraZeneca Extends AI Pacts To Clinical Trials With Oracle Tie Up]]>premium

      
]]> https://feeds.feedblitz.com/~/971820941/0/scrip~AstraZeneca-Extends-AI-Pacts-To-Clinical-Trials-With-Oracle-Tie-Up/https://insights.citeline.com/scrip/digital-technologies/ai/astrazeneca-extends-ai-pacts-to-clinical-trials-with-oracle-tie-up-DO64GUILINAPPFWD7WC7Y6SBGU/
      
]]> Tue, 20 Oct 2026 16:02:36 +0000 https://insights.citeline.com/scrip/therapeutic-category/anticancer/immuno-oncology/gsks-jemperli-approved-in-rectal-cancer-thanks-to-investigator-study-and-novel-endpoint-BG7OPFA2FVGOXPHPZXX5VPHFI4/<![CDATA[GSK’s Jemperli Approved In Rectal Cancer, Thanks To Investigator Study And Novel Endpoint]]>premium

      
]]> https://feeds.feedblitz.com/~/971821424/0/scrip~GSK%e2%80%99s-Jemperli-Approved-In-Rectal-Cancer-Thanks-To-Investigator-Study-And-Novel-Endpoint/https://insights.citeline.com/scrip/therapeutic-category/anticancer/immuno-oncology/gsks-jemperli-approved-in-rectal-cancer-thanks-to-investigator-study-and-novel-endpoint-BG7OPFA2FVGOXPHPZXX5VPHFI4/
      
]]> Tue, 20 Oct 2026 16:11:38 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/arcuss-casdatifan-could-rival-mercks-welireg-in-clear-cell-rcc-REEJLL34NZBX5DKKKU6Q6TRDBA/<![CDATA[Arcus’s Casdatifan Could Rival Merck’s Welireg In Clear-Cell RCC ]]>premium

      
]]> https://feeds.feedblitz.com/~/971828558/0/scrip~Arcus%e2%80%99s-Casdatifan-Could-Rival-Merck%e2%80%99s-Welireg-In-ClearCell-RCC/https://insights.citeline.com/scrip/r-and-d/clinical-trials/arcuss-casdatifan-could-rival-mercks-welireg-in-clear-cell-rcc-REEJLL34NZBX5DKKKU6Q6TRDBA/
      
]]> Tue, 20 Oct 2026 21:20:10 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/veradermics-vdphl01-hits-hair-loss-endpoint-again-12-month-safety-is-next-test-MXQGZPASGFBV5CPKEVYETSTBKM/<![CDATA[Veradermics’ VDPHL01 Hits Hair Loss Endpoint Again, 12-Month Safety Is Next Test ]]>premium

      
]]> https://feeds.feedblitz.com/~/971794343/0/scrip~Veradermics%e2%80%99-VDPHL-Hits-Hair-Loss-Endpoint-Again-Month-Safety-Is-Next-Test/https://insights.citeline.com/scrip/r-and-d/clinical-trials/veradermics-vdphl01-hits-hair-loss-endpoint-again-12-month-safety-is-next-test-MXQGZPASGFBV5CPKEVYETSTBKM/
      
]]> Mon, 19 Oct 2026 21:34:20 +0000 https://insights.citeline.com/scrip/leadership/interviews/revmed-makes-the-case-for-going-it-alone-in-europe-32K36NFJUFBATK4MPWKMGPAHYM/<![CDATA[RevMed Makes The Case For Going It Alone In Europe]]>premium

      
]]> https://feeds.feedblitz.com/~/971790167/0/scrip~RevMed-Makes-The-Case-For-Going-It-Alone-In-Europe/https://insights.citeline.com/scrip/leadership/interviews/revmed-makes-the-case-for-going-it-alone-in-europe-32K36NFJUFBATK4MPWKMGPAHYM/
      
]]> Mon, 19 Oct 2026 18:59:42 +0000 https://insights.citeline.com/scrip/leadership/interviews/baylink-leverages-claudin-69-for-global-first-dual-targeting-adc-push-WC2JZUH2VFFSHB3N4BYNVMJVJY/<![CDATA[Baylink Leverages Claudin 6/9 For Global-First Dual-Targeting ADC Push]]>premium

      
]]> https://feeds.feedblitz.com/~/971803046/0/scrip~Baylink-Leverages-Claudin-For-GlobalFirst-DualTargeting-ADC-Push/https://insights.citeline.com/scrip/leadership/interviews/baylink-leverages-claudin-69-for-global-first-dual-targeting-adc-push-WC2JZUH2VFFSHB3N4BYNVMJVJY/
      
]]> Tue, 20 Oct 2026 06:28:45 +0000 https://insights.citeline.com/scrip/conferences/esmo/esmo26-preview-world-first-results-from-innovent-insilico-mabwell-in-adcs-ai-designed-drugs-GG7WDAP3URASDFJWNDAQEXLGEU/<![CDATA[ESMO 2026 China Preview: First Results From Innovent, InSilico, Mabwell In ADCs, AI-Designed Drugs ]]>premium

      
]]> https://feeds.feedblitz.com/~/971772731/0/scrip~ESMO-China-Preview-First-Results-From-Innovent-InSilico-Mabwell-In-ADCs-AIDesigned-Drugs/https://insights.citeline.com/scrip/conferences/esmo/esmo26-preview-world-first-results-from-innovent-insilico-mabwell-in-adcs-ai-designed-drugs-GG7WDAP3URASDFJWNDAQEXLGEU/
      
]]> Mon, 19 Oct 2026 08:42:41 +0000 https://insights.citeline.com/scrip/business/financing/nouscom-banks-another-120m-to-advance-lynch-vaccine-DIANBYXHNNBHTJDTOLYXNFYTUE/<![CDATA[Nouscom Banks Another €120m To Advance Lynch Vaccine ]]>premium

      
]]> https://feeds.feedblitz.com/~/971782235/0/scrip~Nouscom-Banks-Another-%e2%82%acm-To-Advance-Lynch-Vaccine/https://insights.citeline.com/scrip/business/financing/nouscom-banks-another-120m-to-advance-lynch-vaccine-DIANBYXHNNBHTJDTOLYXNFYTUE/
      
]]> Mon, 19 Oct 2026 14:16:26 +0000 https://insights.citeline.com/scrip/business/deals/merck-kgaa-likes-the-sound-of-silence-CRA3SDDHEJAUZMWUWF7ZE4AUHM/<![CDATA[Merck KGaA Likes The Sound Of Silence ]]>premium

      
]]> https://feeds.feedblitz.com/~/971791751/0/scrip~Merck-KGaA-Likes-The-Sound-Of-Silence/https://insights.citeline.com/scrip/business/deals/merck-kgaa-likes-the-sound-of-silence-CRA3SDDHEJAUZMWUWF7ZE4AUHM/
      
]]> Mon, 19 Oct 2026 20:21:36 +0000 https://insights.citeline.com/scrip/business/deals/roche-strikes-second-deal-with-hansoh-seventh-with-a-china-based-partner-this-year-D75P34SSGRGAPPR3DVUM5Q2BXM/<![CDATA[Roche Strikes Second Deal With Hansoh, Seventh With A China-Based Partner This Year]]>premium

      
]]> https://feeds.feedblitz.com/~/971793671/0/scrip~Roche-Strikes-Second-Deal-With-Hansoh-Seventh-With-A-ChinaBased-Partner-This-Year/https://insights.citeline.com/scrip/business/deals/roche-strikes-second-deal-with-hansoh-seventh-with-a-china-based-partner-this-year-D75P34SSGRGAPPR3DVUM5Q2BXM/
      
]]> Mon, 19 Oct 2026 20:59:21 +0000 https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-vir-biotechnology-gets-a-new-chief-medical-officer-SV6ZDWZ2CZEMHO4RDJABJ37POQ/<![CDATA[Executives On The Move: Vir Biotechnology Gets A New Chief Medical Officer ]]>premium

      
]]> https://feeds.feedblitz.com/~/971772467/0/scrip~Executives-On-The-Move-Vir-Biotechnology-Gets-A-New-Chief-Medical-Officer/https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-vir-biotechnology-gets-a-new-chief-medical-officer-SV6ZDWZ2CZEMHO4RDJABJ37POQ/
      
]]> Mon, 19 Oct 2026 08:12:22 +0000